|
Volumn 57, Issue 2, 2002, Pages 115-121
|
Design, pharmacokinetic, and pharmacodynamic evaluation of soft anticholinergics based on tropyl α-phenylcyclopentylacetate
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATROPINE;
CARBACHOL;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
MUSCARINIC RECEPTOR;
PHENYLCYCLOPENTYLACETYL NALPHA ETHOXYCARBONYLMETHYLTROPINIUM BROMIDE;
PHENYLCYCLOPENTYLACETYL NALPHA ETHOXYCARBONYLMETYLTROPIUM METHYLSULFATE;
PHENYLCYCLOPENTYLACETYL NALPHA METHOXYCARBONYLMETHYLTROPINIUM BROMIDE;
PHENYLCYCLOPENTYLACETYL NALPHA METHOXYCARBONYLMETHYLTROPIUM METHYLSULFATE;
SCOPOLAMINE;
TROPICAMIDE;
TROPYL ALPHA PHENYLCYCLOPENTYLACETATE;
UNCLASSIFIED DRUG;
ARTICLE;
BIOTRANSFORMATION;
BRADYCARDIA;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
MYDRIASIS;
PHARMACODYNAMICS;
RABBIT;
ALGORITHMS;
ANIMALS;
AREA UNDER CURVE;
BIOTRANSFORMATION;
CHOLINERGIC ANTAGONISTS;
DRUG DESIGN;
HEART RATE;
HEMODYNAMIC PROCESSES;
INDICATORS AND REAGENTS;
MALE;
MYDRIATICS;
PHENYLACETATES;
RABBITS;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, CHOLINERGIC;
|
EID: 0036179177
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (28)
|